Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma
The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.
Source: hcplive.com
Aged 6 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aged 6. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aged 6 Today - Breaking & Trending Today